NasdaqGS - NasdaqGS Real Time Price. Currency in USD


Rue du Centre 172
Saint-Sulpice 1025
41 21 694 10 60

IndustryHealth Information Services
Full Time Employees466

Key Executives

NameTitlePayExercisedYear Born
Dr. Jurgi Camblong M.B.A., Ph.D.Co-Founder, CEO & Director1.04MN/A1979
Mr. Ross Jordan Muken B.Sc.Exec. VP, CFO & COON/AN/A1981
Mr. Abhimanyu VermaSr. VP & CTON/AN/AN/A
Dr. Zhenyu Xu Ph.D.Exec. VP & Chief Scientific OfficerN/AN/A1983
Katherine BailonVP of Investor RelationsN/AN/AN/A
Mr. Daan van Well L.L.M., M.B.A.Sr. VP, Chief Legal Officer & Gen. CounselN/AN/A1974
Mr. Kevin PuylaertVP of Bus. Devel. & MarketingN/AN/AN/A
Ms. Manuela Da Silva Valente B.A.Sr. VP & Chief People OfficerN/AN/A1971
Dr. Philippe Menu M.B.A., M.D., Ph.D.Exec. VP, Chief Medical Officer & Chief Product OfficerN/AN/A1982
Ms. Melissa FinocchioSr. VP & Chief Regulatory OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharma customers worldwide. The company was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Corporate Governance

SOPHiA GENETICS SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.